Lilly Loses Round Over Depositions In Zyprexa MDL

Law360, New York (March 26, 2009, 12:00 AM EDT) -- A judge in charge of discovery in the multidistrict litigation over Eli Lilly & Co.'s anti-psychotic drug Zyprexa has denied the drug company's request for an order “for the benefit of wary physicians” that doctors can testify on patient records, ruling that Lilly cannot preempt disputes over future depositions.

In an order signed Tuesday in the U.S. District Court for the Eastern District of New York, Magistrate Judge Roann L. Mann rejected Lilly's request to advise potential prescriber-deponents as to how the company may use “de-identified”...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.